1. Orphan Drug Act Public Law 97-414. 97th Congress. US. 1983. p. 2049–66. Available online at: https://www.fda.gov/media/99546/download.
2. European Parliament, Council of the European Union. Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products. Official J Eur Communities. 2000;L018(43):1–6.
3. Choi EK, Lee JW. Main results of statistical yearbook of rare diseases. Public Health Weekly Rep PHWR. 2021;14(28):2025–36.
4. Meng Q, Li R, Cheng G, Blas E. Provision and financial burden of TB services in a financially decentralized system: a case study from Shandong, China. Int J Health Plann Manage. 2004;19(1):5-S62.
5. Song YJ. The South Korean health care system. JAMAJ. 2009;3:206–9.